222 related articles for article (PubMed ID: 33620642)
1. External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model.
Casadei R; Ricci C; Ingaldi C; Cornacchia A; Migliori M; Di Marco M; Pagano N; Serra C; Alberici L; Minni F
Updates Surg; 2021 Apr; 73(2):429-438. PubMed ID: 33620642
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
4. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
[TBL] [Abstract][Full Text] [Related]
5. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.
Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A
Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557
[TBL] [Abstract][Full Text] [Related]
6. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less.
Jung W; Park T; Kim Y; Park H; Han Y; He J; Wolfgang CL; Blair A; Rashid MF; Kluger MD; Su GH; Chabot JA; Yang CY; Lou W; Valente R; Del Chiaro M; Shyr YM; Wang SE; van Huijgevoort NCM; Besselink MG; Yang Y; Kim H; Kwon W; Kim SW; Jang JY
Br J Surg; 2019 Dec; 106(13):1829-1836. PubMed ID: 31441048
[TBL] [Abstract][Full Text] [Related]
7. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.
Correa-Gallego C; Do R; Lafemina J; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2013 Dec; 20(13):4348-55. PubMed ID: 24046103
[TBL] [Abstract][Full Text] [Related]
8. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
9. Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study.
Kim HS; Song W; Choo W; Lee S; Han Y; Bassi C; Salvia R; Marchegiani G; Wolfgang CL; He J; Blair AB; Kluger MD; Su GH; Kim SC; Song KB; Yamamoto M; Hatori T; Yang CY; Yamaue H; Hirono S; Satoi S; Fujii T; Hirano S; Lou W; Hashimoto Y; Shimizu Y; Del Chiaro M; Valente R; Lohr M; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Shyr YM; Wang SE; Han HS; Yoon YS; Besselink MG; van Huijgevoort NCM; Sho M; Nagano H; Kim SG; Honda G; Yang Y; Yu HC; Yang JD; Chung JC; Nagakawa Y; Seo HI; Lee S; Kim H; Kwon W; Park T; Jang JY
J Hepatobiliary Pancreat Sci; 2023 Jan; 30(1):133-143. PubMed ID: 33811460
[TBL] [Abstract][Full Text] [Related]
10. Natural history and optimal treatment strategy of intraductal papillary mucinous neoplasm of the pancreas: Analysis using a nomogram and Markov decision model.
Han Y; Jang JY; Oh MY; Kim HS; Byun Y; Kang JS; Kim SH; Lee KB; Kim H; Kwon W
J Hepatobiliary Pancreat Sci; 2021 Feb; 28(2):131-142. PubMed ID: 33283481
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
[TBL] [Abstract][Full Text] [Related]
12. Prediction of malignant intraductal papillary mucinous neoplasm: A nomogram based on clinical information and radiological outcomes.
Huang X; Guo T; Zhang Z; Cai M; Guo X; Zhang J; Yu Y
Cancer Med; 2023 Aug; 12(16):16958-16971. PubMed ID: 37434479
[TBL] [Abstract][Full Text] [Related]
13. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
Tanaka M
Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
15. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
17. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
[TBL] [Abstract][Full Text] [Related]
18. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
19. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
Brunner M; Weber GF; Kersting S; Grützmann R
Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
